DK1405621T3 - Fremgangsmåde til fremstilling af tablet - Google Patents

Fremgangsmåde til fremstilling af tablet

Info

Publication number
DK1405621T3
DK1405621T3 DK02738759.6T DK02738759T DK1405621T3 DK 1405621 T3 DK1405621 T3 DK 1405621T3 DK 02738759 T DK02738759 T DK 02738759T DK 1405621 T3 DK1405621 T3 DK 1405621T3
Authority
DK
Denmark
Prior art keywords
grain body
tablet
preparation
marking
covered
Prior art date
Application number
DK02738759.6T
Other languages
English (en)
Inventor
Daisuke Izutsu
Keiichi Yamamoto
Yoshio Mizukami
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of DK1405621T3 publication Critical patent/DK1405621T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/007—Marking tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
    • B30B11/08—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B15/00—Details of, or accessories for, presses; Auxiliary measures in connection with pressing
    • B30B15/34—Heating or cooling presses or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
DK02738759.6T 2001-06-20 2002-06-19 Fremgangsmåde til fremstilling af tablet DK1405621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001186433 2001-06-20
PCT/JP2002/006087 WO2003000169A1 (fr) 2001-06-20 2002-06-19 Procede de fabrication de comprimes

Publications (1)

Publication Number Publication Date
DK1405621T3 true DK1405621T3 (da) 2011-07-18

Family

ID=19025878

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02738759.6T DK1405621T3 (da) 2001-06-20 2002-06-19 Fremgangsmåde til fremstilling af tablet

Country Status (11)

Country Link
US (1) US8765176B2 (da)
EP (1) EP1405621B1 (da)
JP (1) JP5002044B2 (da)
AT (1) ATE508725T1 (da)
CA (1) CA2451135C (da)
CY (1) CY1111745T1 (da)
DK (1) DK1405621T3 (da)
ES (1) ES2366430T3 (da)
NO (1) NO333897B1 (da)
PT (1) PT1405621E (da)
WO (1) WO2003000169A1 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7363569B2 (en) 2001-06-29 2008-04-22 Intel Corporation Correcting for data losses with feedback and response
US7231653B2 (en) 2001-09-24 2007-06-12 Intel Corporation Method for delivering transport stream data
WO2004035052A1 (ja) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
GB0320522D0 (en) 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
WO2006032828A1 (en) * 2004-09-24 2006-03-30 Bioprogress Technology Limited Additional improvements in powder compaction and enrobing
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
EP1742630A4 (en) * 2004-04-16 2010-01-20 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND PROKINETIC AGENT
RU2382637C2 (ru) * 2004-04-30 2010-02-27 Астеллас Фарма Инк. Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006076971A (ja) * 2004-09-13 2006-03-23 Basf Ag 口腔内崩壊錠
EP1944005A3 (en) * 2004-09-24 2008-07-23 BioProgress Technology Limited Additional improvements in powder compaction and enrobing
WO2006079496A1 (en) * 2005-01-26 2006-08-03 Lek Pharmaceuticals D.D. New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance
FR2889995A1 (fr) * 2005-08-29 2007-03-02 Thierry Lemoine Dispositif pour maitriser la temperature a l'interieur d'une presse a comprimer lors de la compression d'une poudre
US20070092553A1 (en) * 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
GB0522188D0 (en) * 2005-10-31 2005-12-07 Bioprogress Technology Ltd Apparatus for tablet coating
US8486450B2 (en) 2005-12-28 2013-07-16 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
EP1810819B1 (de) * 2006-01-18 2012-06-13 Fette GmbH Rundläuferpresse und Verfahren zur Überwachung der Produktion von Tabletten in einer Rundläuferpresse
DE102006002359B4 (de) * 2006-01-18 2009-01-02 Fette Gmbh Vorrichtung und Verfahren zur Überwachung der Produktion von Tabletten in einer Rundläuferpresse
CN101410094B (zh) * 2006-01-27 2013-04-17 阿普塔利斯制药股份有限公司 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
KR20140088230A (ko) * 2006-01-27 2014-07-09 앱탈리스 파마테크, 인코포레이티드 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
JP2007308479A (ja) * 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 固体分散体製剤
CA2667682A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US8765187B2 (en) 2007-07-17 2014-07-01 Asahi Kasei Chemicals Corporation Aqueous composition
JP2011512416A (ja) 2008-02-20 2011-04-21 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法
EP2427166B1 (en) 2009-05-07 2013-10-16 Gea Pharma Systems Limited Tablet production module and method for continuous production of tablets
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
US10780628B2 (en) * 2014-07-18 2020-09-22 Fusion3 Design LLC Apparatus and method for fabricating three-dimensional objects
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN110506039A (zh) 2016-10-11 2019-11-26 阿尔维纳斯股份有限公司 用于雄激素受体靶向降解的化合物和方法
US11413839B2 (en) * 2018-12-14 2022-08-16 Natoli Engineering Company, Inc. Device to level a feeder platform
CN110755268B (zh) * 2019-11-14 2022-03-29 西安交通大学医学院第二附属医院 一种防治缓慢性心律失常的复脉灵胶囊制备装置
CR20220630A (es) 2020-05-09 2023-01-23 Arvinas Operations Inc Métodos para fabricar un compuesto bifuncional, formas ultrapuras del compuesto bifuncional y formas de dosificación que comprenden el mismo
CN111714375B (zh) * 2020-07-02 2022-08-09 山东益健药业有限公司 阿奇霉素分散片制备系统
TW202535392A (zh) 2023-12-08 2025-09-16 美商亞文納營運公司 使用雄性素受體降解劑治療脊髓延髓性肌肉萎縮

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230693A (en) 1975-04-21 1980-10-28 Armour-Dial, Inc. Antacid tablets and processes for their preparation
US4601866A (en) 1979-11-19 1986-07-22 Chinoin Process for tablet production
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
AU4513393A (en) * 1992-07-17 1994-02-14 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
JPH0739515Y2 (ja) 1993-07-16 1995-09-13 株式会社畑鉄工所 回転式粉末圧縮成型装置
JP2821089B2 (ja) 1994-06-27 1998-11-05 株式会社菊水製作所 回転式粉末圧縮成形機
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
GB9422925D0 (en) 1994-11-14 1995-01-04 Unilever Plc Detergent compositions
JPH0947900A (ja) 1995-06-01 1997-02-18 Hitachi Chem Co Ltd ロータリー式粉粒体圧縮成形機
ATE286394T1 (de) * 1995-09-21 2005-01-15 Pharma Pass Ii Llc Ein säurelabile omeprazol enthaltende arzneizusammensetzung und verfahren zu deren herstellung
WO1999038513A1 (en) * 1998-01-30 1999-08-05 Sepracor Inc. R-lansoprazole compositions and methods
DE69934505T2 (de) 1998-05-18 2007-10-04 Takeda Pharmaceutical Co. Ltd. Im munde zerfallende tablette enthaltend ein benzimidazole
TW585786B (en) 1998-07-28 2004-05-01 Takeda Chemical Industries Ltd Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
US6787082B1 (en) 1999-01-29 2004-09-07 Takeda Chemical Industries, Ltd. Compressing mallet with coating treatment
US6174902B1 (en) * 1999-04-28 2001-01-16 Sepracor Inc. R-rabeprazole compositions and methods
JP4200593B2 (ja) * 1999-06-22 2008-12-24 昭和電工株式会社 結晶質ｌ−アスコルビン酸−２−リン酸エステルナトリウム塩およびその製造方法
JP2001026533A (ja) 1999-07-12 2001-01-30 Kao Corp 錠剤の製造法
WO2001026632A1 (fr) * 1999-10-13 2001-04-19 Kyowa Hakko Kogyo Co., Ltd. Produit moule par compression et son procede de production

Also Published As

Publication number Publication date
CA2451135A1 (en) 2003-01-03
WO2003000169A1 (fr) 2003-01-03
US20040131675A1 (en) 2004-07-08
US8765176B2 (en) 2014-07-01
NO333897B1 (no) 2013-10-14
EP1405621A4 (en) 2007-10-24
JP5002044B2 (ja) 2012-08-15
ES2366430T3 (es) 2011-10-20
CA2451135C (en) 2012-10-09
EP1405621A1 (en) 2004-04-07
JP2010270160A (ja) 2010-12-02
CY1111745T1 (el) 2015-10-07
NO20035655D0 (no) 2003-12-17
EP1405621B1 (en) 2011-05-11
ATE508725T1 (de) 2011-05-15
PT1405621E (pt) 2011-05-31
NO20035655L (no) 2004-02-17

Similar Documents

Publication Publication Date Title
DK1405621T3 (da) Fremgangsmåde til fremstilling af tablet
WO2004012630A3 (en) Separable medical devices comprising a holding material
CY1111821T1 (el) Φαρμακευτικες συνθeσεις οι οποιες περιλαμβανουν ενα οπιουχο αναλγητικο
BR0211912B1 (pt) pelÍcula microporosa de méltiplas camadas.
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
DE60041166D1 (de) Halbleiterdünnschichtherstellungssystem
ATE277646T1 (de) Dünnfilmstent
DK1041975T3 (da) Hastighedskontrollerende membraner til anordninger til kontrolleret indførsel af medikament
DK1128811T3 (da) Lægemiddelleveringsindretning, især til levering af progestiner og estrogener
DE60230886D1 (de) Systeme, verfahren und geräte zur herstellung von dosierungsformen
ZA200306360B (en) Method and device for producing thin wafers from a film of active ingredients.
SG115478A1 (en) Thin film transistor and method for manufacturing the same
AU2003302990A1 (en) Chemical amplification type silicone base positive photoresist composition
AU2003280591A8 (en) Method for forming thin silver mirror film, and method for forming coating film comprising thin silver mirror film
IS7092A (is) Einfaldur skammtur af asíþrómýsíni til meðhöndlunar á sýkingum í öndunarvegi
DE69937898D1 (de) Mehrschichtige Tablette, enthaltend Rosiglitazone
DK1326584T3 (da) Fremföringssystem og fremgangsmåde til behandling eller forebyggelse af otitis media
EP1348443A4 (en) COMBINED MEDICINES
DK0765158T3 (da) Bærer for aktive stoffer til styret afgivelse af aktive stoffer i den gastrointestinale kanal med forsinket passage gennem
TR199901165A3 (tr) Piretroid bilesimi ve salgin hastaliklari için bunu içeren bilesikler.
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
TR200000441A3 (tr) Organik azitlerin imali için islem.
AU2003248483A1 (en) Mask based on the use of silver
EP1571148A4 (en) APPROVED OF 3-PHENYLCINNOLINE AND ANTI-TUMOR AGENT CONTAINING THE SAME
NL1016128A1 (nl) Koude kathode veldemissie inrichting, koude kathode veldemissie weergeefeenheid, en processen voor de vervaardiging daarvan.